STOCK TITAN

[144] BKV Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

BKV Corp insider notice reports a proposed sale under Rule 144 of 15,000 common shares through Charles Schwab with an aggregate market value of $347,816, and lists prior sales by the same person totaling 40,187 shares during the past three months for gross proceeds of $660,491 across three transactions. The shares to be sold were acquired on 08/22/2024 as equity compensation (RSU/PSU) from BKV Corp. The filing includes the seller's representation that they are not aware of undisclosed material adverse information. The notice identifies the broker as Charles Schwab & Co., Inc. and the planned approximate sale date as 10/01/2025.

L'avviso interno di BKV Corp riporta una vendita proposta ai sensi della Rule 144 di 15.000 azioni comuni tramite Charles Schwab, con un valore di mercato complessivo di 347.816 dollari, e elenca vendite precedenti da parte della stessa persona per un totale di 40.187 azioni nelle ultime tre mesi per proventi lordi di 660.491 dollari attraverso tre operazioni. Le azioni da vendere sono state acquisite il 22/08/2024 come compenso in equity (RSU/PSU) da BKV Corp. L'inserimento include la dichiarazione del venditore che non è a conoscenza di informazioni materialmente adverse non divulgate. L'avviso identifica il broker come Charles Schwab & Co., Inc. e la data prevista di vendita approssimativa come 01/10/2025.
El aviso interno de BKV Corp informa de una venta propuesta conforme a la Regla 144 de 15.000 acciones comunes a través de Charles Schwab, con un valor de mercado agregado de 347.816 dólares, y enumera ventas previas de la misma persona por un total de 40.187 acciones durante los últimos tres meses, por ingresos brutos de 660.491 dólares en tres transacciones. Las acciones que se venderán fueron adquiridas el 22/08/2024 como compensación en acciones (RSU/PSU) de BKV Corp. La presentación incluye la declaración del vendedor de que no tiene conocimiento de información material adversa no divulgada. El aviso identifica al corredor como Charles Schwab & Co., Inc. y la fecha de venta prevista aproximadamente como 01/10/2025.
BKV Corp 내부자 공고는 규칙 144에 따라 Charles Schwab를 통해 15,000주 보통주를 매도하려는 제안을 보고하며 총 시장가치는 347,816달러이고, 지난 3개월 동안 동일인의 총 40,187주에 대한 이전 매도와 3건의 거래를 통해 660,491달러의 총수익을 기록한다. 매도 예정 주식은 2024-08-22에 BKV Corp로부터 RSU/PSU 등 주식 보상으로 취득되었다. 제출서는 매도자가 공개되지 않은 중요한 악재 정보에 대해 인지하고 있지 않다는 진술을 포함한다. 공지는 브로커를 Charles Schwab & Co., Inc.로 식별하고 계획된 대략적인 매도일을 2025-10-01로 명시한다.
Un avis interne de BKV Corp fait état d'une vente proposée selon la règle 144 de 15 000 actions ordinaires via Charles Schwab, avec une valeur de marché globale de 347 816 dollars, et répertorie des ventes antérieures par la même personne totalisant 40 187 actions au cours des trois derniers mois pour des produits bruts de 660 491 dollars répartis sur trois transactions. Les actions à vendre ont été acquises le 22/08/2024 en tant que compensation en actions (RSU/PSU) de BKV Corp. Le dépôt comprend la déclaration du vendeur selon laquelle il n'est pas au courant d'informations matérielles défavorables non divulguées. L'avis identifie le courtier comme Charles Schwab & Co., Inc. et la date de vente approximative prévue comme le 01/10/2025.
Ein Insiderhinweis von BKV Corp meldet einen geplanten Verkauf gemäß Regel 144 von 15.000 Stammaktien über Charles Schwab mit einem aggregierten Marktwert von 347.816 USD und listet vorherige Verkäufe derselben Person über insgesamt 40.187 Aktien in den letzten drei Monaten für Bruttoerlöse von 660.491 USD in drei Transaktionen auf. Die zu verkaufenden Aktien wurden am 22.08.2024 als Aktienvergütung (RSU/PSU) von BKV Corp erworben. Die Einreichung enthält die Erklärung des Verkäufers, dass ihm keine nicht offenbarten wesentlichen nachteilhaften Informationen bekannt sind. Die Mitteilung identifiziert den Broker als Charles Schwab & Co., Inc. und das voraussichtliche Verkaufsdatum als ca. 01.10.2025.
إشعار داخلي من BKV Corp يعلن عن بيع مقترح بموجب القاعدة 144 لــ 15,000 سهم عادي من خلال Charles Schwab، بقيمة سوقية إجمالية تبلغ 347,816 دولارًا، ويذكر مبيعات سابقة من نفس الشخص بإجمالـي 40,187 سهـمًا خلال الثلاثة أشهر الماضية مقابل عوائد إجمالية قدرها 660,491 دولارًا عبر ثلاث معاملات. الأسهم التي ستباع قد خُصِّصت في 22/08/2024 كتعويض أسهم (RSU/PSU) من BKV Corp. يتضمن الملف التزام البائع بأنه ليس لديه علم بأي معلومات جوهرية سلبية لم تُكشف. الإشعار يحدد الوسيط كـ Charles Schwab & Co., Inc. وتاريخ البيع المخطط التقريبي كـ 01/10/2025.
BKV Corp 内部通知报告了一项根据Rule 144通过 Charles Schwab出售15,000股普通股的提议,市值合计347,816美元,并列出在过去三个月内同一人此前已出售的40,187股,总毛收入为660,491美元,分三笔交易完成。拟出售的股票于2024-08-22以来自BKV Corp的股权补偿(RSU/PSU)获得。该备案包含卖方声明,表示其并不知悉未披露的重大不利信息。通知将经纪商识别为Charles Schwab & Co., Inc.,计划出售的近似日期为2025-10-01。
Positive
  • Transparent disclosure of proposed sale under Rule 144 with broker, share counts, and acquisition details
  • Securities were acquired as equity compensation (RSU/PSU), indicating the sale relates to vested awards rather than an outside transaction
  • Seller represents no undisclosed material information, which is a compliance standard for such filings
Negative
  • Insider selling activity is ongoing: 40,187 shares sold in the past three months and 15,000 shares proposed for sale, which could concern some investors
  • Filing lacks context on the seller's role or any Rule 10b5-1 plan adoption date, limiting insight into whether sales are routine or timed

Insights

TL;DR: Insider plans to sell equity-compensation shares; recent sales show ongoing disposition but amounts are small relative to total shares outstanding.

The filing shows a proposed Rule 144 sale of 15,000 common shares acquired as RSUs/PSUs on 08/22/2024, to be executed via Charles Schwab on or about 10/01/2025. The same insider sold 10,000, 10,000 and 9,187 shares in July–September 2025 for combined gross proceeds of $660,491. With 84,711,220 shares outstanding reported in this form, the sales disclosed here represent a de minimis percentage of outstanding stock, suggesting limited immediate market impact. The disclosure and representation regarding material nonpublic information are standard and appropriate for compliance.

TL;DR: The notice documents routine insider selling of vested equity awards and includes required representations; governance risk appears limited from the filing alone.

The securities were granted as equity compensation and the seller has followed Rule 144 disclosure procedures by filing a Form 144 and identifying the broker. The aggregated recent disposals total 40,187 shares, and the proposed sale is 15,000 shares. Absent additional context—such as executive role, timing relative to company events, or larger sales—the filing reflects compliant transfer of vested awards rather than an obvious governance red flag. The filing does not state any plan adoption date under Rule 10b5-1.

L'avviso interno di BKV Corp riporta una vendita proposta ai sensi della Rule 144 di 15.000 azioni comuni tramite Charles Schwab, con un valore di mercato complessivo di 347.816 dollari, e elenca vendite precedenti da parte della stessa persona per un totale di 40.187 azioni nelle ultime tre mesi per proventi lordi di 660.491 dollari attraverso tre operazioni. Le azioni da vendere sono state acquisite il 22/08/2024 come compenso in equity (RSU/PSU) da BKV Corp. L'inserimento include la dichiarazione del venditore che non è a conoscenza di informazioni materialmente adverse non divulgate. L'avviso identifica il broker come Charles Schwab & Co., Inc. e la data prevista di vendita approssimativa come 01/10/2025.
El aviso interno de BKV Corp informa de una venta propuesta conforme a la Regla 144 de 15.000 acciones comunes a través de Charles Schwab, con un valor de mercado agregado de 347.816 dólares, y enumera ventas previas de la misma persona por un total de 40.187 acciones durante los últimos tres meses, por ingresos brutos de 660.491 dólares en tres transacciones. Las acciones que se venderán fueron adquiridas el 22/08/2024 como compensación en acciones (RSU/PSU) de BKV Corp. La presentación incluye la declaración del vendedor de que no tiene conocimiento de información material adversa no divulgada. El aviso identifica al corredor como Charles Schwab & Co., Inc. y la fecha de venta prevista aproximadamente como 01/10/2025.
BKV Corp 내부자 공고는 규칙 144에 따라 Charles Schwab를 통해 15,000주 보통주를 매도하려는 제안을 보고하며 총 시장가치는 347,816달러이고, 지난 3개월 동안 동일인의 총 40,187주에 대한 이전 매도와 3건의 거래를 통해 660,491달러의 총수익을 기록한다. 매도 예정 주식은 2024-08-22에 BKV Corp로부터 RSU/PSU 등 주식 보상으로 취득되었다. 제출서는 매도자가 공개되지 않은 중요한 악재 정보에 대해 인지하고 있지 않다는 진술을 포함한다. 공지는 브로커를 Charles Schwab & Co., Inc.로 식별하고 계획된 대략적인 매도일을 2025-10-01로 명시한다.
Un avis interne de BKV Corp fait état d'une vente proposée selon la règle 144 de 15 000 actions ordinaires via Charles Schwab, avec une valeur de marché globale de 347 816 dollars, et répertorie des ventes antérieures par la même personne totalisant 40 187 actions au cours des trois derniers mois pour des produits bruts de 660 491 dollars répartis sur trois transactions. Les actions à vendre ont été acquises le 22/08/2024 en tant que compensation en actions (RSU/PSU) de BKV Corp. Le dépôt comprend la déclaration du vendeur selon laquelle il n'est pas au courant d'informations matérielles défavorables non divulguées. L'avis identifie le courtier comme Charles Schwab & Co., Inc. et la date de vente approximative prévue comme le 01/10/2025.
Ein Insiderhinweis von BKV Corp meldet einen geplanten Verkauf gemäß Regel 144 von 15.000 Stammaktien über Charles Schwab mit einem aggregierten Marktwert von 347.816 USD und listet vorherige Verkäufe derselben Person über insgesamt 40.187 Aktien in den letzten drei Monaten für Bruttoerlöse von 660.491 USD in drei Transaktionen auf. Die zu verkaufenden Aktien wurden am 22.08.2024 als Aktienvergütung (RSU/PSU) von BKV Corp erworben. Die Einreichung enthält die Erklärung des Verkäufers, dass ihm keine nicht offenbarten wesentlichen nachteilhaften Informationen bekannt sind. Die Mitteilung identifiziert den Broker als Charles Schwab & Co., Inc. und das voraussichtliche Verkaufsdatum als ca. 01.10.2025.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What is reported in the BKV Form 144 filing?

The form reports a proposed sale of 15,000 common shares (aggregate market value $347,816) acquired as RSU/PSU on 08/22/2024, to be sold via Charles Schwab around 10/01/2025.

How many shares did the insider sell in the past three months according to the filing?

The filing lists three recent sales totaling 40,187 shares for gross proceeds of $660,491.

Were the shares acquired by purchase or compensation?

The securities were acquired as equity compensation (RSU/PSU) from BKV Corp on 08/22/2024.

Which broker is handling the proposed sale?

The proposed sale names Charles Schwab & Co., Inc. as the broker.

Does the filing indicate any undisclosed material information?

The seller signed the notice representing they do not know of any material adverse information about the issuer that has not been publicly disclosed.
BKV Corp.

NYSE:BKV

BKV Rankings

BKV Latest News

BKV Latest SEC Filings

BKV Stock Data

2.12B
16.79M
80.09%
20.36%
1.1%
Oil & Gas E&P
Crude Petroleum & Natural Gas
Link
United States
DENVER